Viewing Study NCT01144403


Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2025-12-30 @ 3:17 AM
Study NCT ID: NCT01144403
Status: TERMINATED
Last Update Posted: 2016-10-18
First Post: 2010-06-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.
Sponsor: Hoffmann-La Roche
Organization: